Reaction
Foetal Exposure During Delivery reporting signals
As of the last recalculation, Foetal Exposure During Delivery appears in 676 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 943.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Misoprostol | 207 | 943.0 | 963.5 |
| Nevirapine | 112 | 458.0 | 463.7 |
| Bupivacaine | 73 | 269.6 | 271.7 |
| Zidovudine | 59 | 148.7 | 149.4 |
| Lamivudine Oral | 63 | 84.5 | 84.7 |
| Lamivudine | 63 | 69.1 | 69.3 |
| Cefazolin Sodium | 23 | 60.8 | 60.9 |
| Cefazolin | 16 | 55.3 | 55.4 |
| Rocuronium Bromide | 20 | 53.8 | 53.9 |
| Norepinephrine Bitartrate | 23 | 50.9 | 51.0 |
| Norepinephrine | 15 | 44.2 | 44.2 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 9 | 31.2 | 31.2 |
| Labetalol | 13 | 30.6 | 30.6 |
| Lidocaine Hydrochloride | 55 | 30.5 | 30.5 |
| Fentanyl | 80 | 28.2 | 28.3 |
| Dolutegravir Sodium | 8 | 27.6 | 27.6 |
| Ritonavir 100 Mg | 13 | 27.3 | 27.3 |
| Atazanavir | 12 | 26.2 | 26.2 |
| Lidicaine | 39 | 26.0 | 26.0 |
| Burn Relief | 39 | 26.0 | 26.0 |
| Lidocaine Hydrochloride And Epinephrine | 39 | 25.9 | 26.0 |
| Lidocaine, Menthol | 39 | 25.6 | 25.7 |
| Propofol | 27 | 23.7 | 23.7 |
| Sevoflurane | 6 | 22.4 | 22.4 |
| Raltegravir | 10 | 18.9 | 18.9 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 18.0 | 18.0 |
| Fentanyl Citrate | 10 | 17.5 | 17.5 |